Panel Discussion: Emerging Treatments for Dry AMD & GA – Therapeutic Avenues, Clinical Trials & Future Directions

Time: 10:30 am
day: Day One


  • Examine the current treatment options and emerging targeted therapies
  • If targeted therapies show limited efficacy as single agents, can the combination of several targeted
    therapies be of benefit to Dry-AMD patients?
  • How can the industry design novel therapeutic strategies for the treatment of dry-AMD?